{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:05:58Z","timestamp":1773979558015,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","content-domain":{"domain":["journalofpsychiatricresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jpsychires.2014.01.013","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T16:46:46Z","timestamp":1391273206000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Effects of escitalopram\/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic\u2013pituitary\u2013adrenal-axis activity in relation to antidepressant effectiveness"],"prefix":"10.1016","volume":"52","author":[{"given":"Caroline","family":"Nothdurfter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schmotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Sarubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Laenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitta","family":"Bondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2014.01.013_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mp.2011.133","article-title":"Can adult neurogenesis buffer stress responses and depressive behaviour?","volume":"17","author":"Anacker","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2011.26","article-title":"Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor","volume":"16","author":"Anacker","year":"2011","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90027-Z","article-title":"Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study","volume":"44","author":"Asnis","year":"1992","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib4","first-page":"185","article-title":"Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression","volume":"29","author":"Barden","year":"2004","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1345\/aph.1M193","article-title":"Safety and efficacy of quetiapine in bipolar depression","volume":"43","author":"Bogart","year":"2009","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI115086","article-title":"Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications","volume":"87","author":"Brady","year":"1991","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-003-1766-6","article-title":"Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects","volume":"174","author":"Cohrs","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11587620-000000000-00000","article-title":"If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies","volume":"71","author":"Connolly","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib11","first-page":"49","article-title":"Neuroendocrine effects of quetiapine in healthy volunteers","volume":"8","author":"de Borja Goncalves","year":"2005","journal-title":"The International Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib12","series-title":"Computer science: a first course","author":"Forsythe","year":"1969"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib13","article-title":"Receptor targets for antidepressant therapy in bipolar disorder: an overview","author":"Fountoulakis","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib14","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.4088\/JCP.9078tx1c","article-title":"A\u00a0review of the current guidelines for depression treatment","volume":"71","author":"Gelenberg","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/dot.1999.35.3.533849","article-title":"Quetiapine fumarate (Seroquel): a new atypical antipsychotic","volume":"35","author":"Goldstein","year":"1999","journal-title":"Drugs Today"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib16","unstructured":"Goldstein JM, Christoph G, Grimm S, Liu JW, Widzowski D, Brecher M. Unique mechanism of action for the antidepressant properties of the atypical antipsychotic quetiapine. In: Poster presented at the American Psychiatric Association's 160th annual meeting. San Diego, California, USA; May 19\u201324 2007."},{"key":"10.1016\/j.jpsychires.2014.01.013_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A\u00a0rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jpsychires.2004.01.010","article-title":"Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX\/CRH-test response","volume":"38","author":"Hatzinger","year":"2004","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.psych.093008.100321","article-title":"Stress hormone regulation: biological role and translation into therapy","volume":"61","author":"Holsboer","year":"2010","journal-title":"The Annual Review of Psychology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/j.jpsychires.2014.01.013_bib23","article-title":"Second-generation antipsychotics for major depressive disorder and dysthymia","author":"Komossa","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0306-4530(99)00029-3","article-title":"Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects","volume":"24","author":"Laakmann","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib25","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib26","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1517\/14656560903448837","article-title":"Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials","volume":"10","author":"McIntyre","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/0033-2909.133.1.25","article-title":"If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans","volume":"133","author":"Miller","year":"2007","journal-title":"Psychological Bulletin"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3956(98)00003-X","article-title":"cAMP-dependent phosphorylation system after short and long-term administration of moclobemide","volume":"32","author":"Mori","year":"1998","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib29","first-page":"11","article-title":"Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function","volume":"30","author":"Nikisch","year":"2009","journal-title":"Neuroendocrinology Letters"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00213-005-0034-3","article-title":"Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response","volume":"181","author":"Nikisch","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2008.09.010","article-title":"Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study","volume":"58","author":"Nikisch","year":"2008","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hup.970","article-title":"Quetiapine augmentation in depressed patients with partial response to antidepressants","volume":"23","author":"Olver","year":"2008","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000308493.93003.92","article-title":"Augmentation of antidepressants with atypical antipsychotics: a review of the current literature","volume":"14","author":"Philip","year":"2008","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psyneuen.2013.10.008","article-title":"Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression","volume":"39","author":"Sarubin","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2826.2006.01516.x","article-title":"Neuroendocrinological mechanisms of actions of antidepressant drugs","volume":"19","author":"Schule","year":"2007","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib37","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0278-5846(02)00264-6","article-title":"Endocrinological effects of mirtazapine in healthy volunteers","volume":"26","author":"Schule","year":"2002","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00213-006-0382-7","article-title":"Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients","volume":"186","author":"Schule","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib39","doi-asserted-by":"crossref","first-page":"e4324","DOI":"10.1371\/journal.pone.0004324","article-title":"The combined dexamethasone\/CRH Test (DEX\/CRH test) and prediction of acute treatment response in major depression","volume":"4","author":"Schule","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1586\/ern.09.52","article-title":"Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression","volume":"9","author":"Schule","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000126180","article-title":"Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in\u00a0vivo","volume":"55","author":"Seckl","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0447.2007.01130.x","article-title":"Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder","volume":"117","author":"Shelton","year":"2008","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.300.3.1085","article-title":"Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment","volume":"300","author":"Stout","year":"2002","journal-title":"Journal of Pharmacological and Experimental Therapeutics"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-002-1016-3","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions","volume":"161","author":"Tarazi","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/npp.2011.306","article-title":"Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review","volume":"37","author":"Undurraga","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S1092852900020307","article-title":"Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study","volume":"14","author":"Weisler","year":"2009","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.jpsychires.2014.01.013_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0b013e3283430a0e","article-title":"Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials","volume":"26","author":"Zhornitsky","year":"2011","journal-title":"International Clinical Psychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T00:25:41Z","timestamp":1538871941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395614000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":46,"alternative-id":["S0022395614000223"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.01.013","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of escitalopram\/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic\u2013pituitary\u2013adrenal-axis activity in relation to antidepressant effectiveness","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}